Last checked at 12 Nov 2021 16:55
LONDON MARKET CLOSE: Muted end to US inflation-dominated week
LONDON MARKET CLOSE: Muted end to US inflation-dominated week
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News2
AZN Share
Chat
AZN Share
Trades18,685
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
Astrazeneca Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
11,352.00
Bid:
11,348.00
Ask:
11,350.00
Change:
84.00 (0.75%)
Spread:
2.00 (0.018%)
Open:
11,288.00
High:
11,412.00
Low:
11,288.00
Prev. Close:
11,268.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.12 Nov 2021 13:44
UPDATE 1-GSK-Vir COVID-19 antibody works as shot in the arm as well as infusion
(Adds background on rival products)By Ludwig Burger and Pushkala AripakaNov 12 (Reuters) - Britain's GSK and partner Vir said on Friday their antibody-based COVID-19 drug was shown in a trial to work as well when given as a shot in the arm awhen a...
Read more12 Nov 2021 12:07
LONDON MARKET MIDDAY: Stocks lack direction amid profit-taking
LONDON MARKET MIDDAY: Stocks lack direction amid profit-taking
Read more12 Nov 2021 10:56
TOP NEWS SUMMARY: Test case for Japan conglomerates as Toshiba splits
TOP NEWS SUMMARY: Test case for Japan conglomerates as Toshiba splits
Read more12 Nov 2021 10:36
UPDATE 2-AstraZeneca, commodity stocks drag down UK's FTSE 100
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* AstraZeneca slumps after profit miss* Miners, oil stocks weigh after dollar dents commodity prices* FTSE 100 down 0.5%, FTSE 250 ends flat...
Read more12 Nov 2021 09:29
GLOBAL MARKETS-European shares hit new highs, firm dollar dents oil
* U.S. inflation shock eases, helping stocks to steady* Dollar highest since July 2020 pressures crude oil* Richemont leads surge in luxury stocks* STOXX index, Paris blue chips hit record highs* Short-dated U.S. Treasury yields edge higherBy Huw Jon...
Read more12 Nov 2021 09:04
LONDON MARKET OPEN: Astra drags on FTSE 100; pound recovers a bit
LONDON MARKET OPEN: Astra drags on FTSE 100; pound recovers a bit
Read more12 Nov 2021 08:51
TOP NEWS: AstraZeneca profit takes hit but revenue gets Covid booster
TOP NEWS: AstraZeneca profit takes hit but revenue gets Covid booster
Read more12 Nov 2021 08:17
LONDON BRIEFING: AstraZeneca holds guidance as vaccine revenue surges
LONDON BRIEFING: AstraZeneca holds guidance as vaccine revenue surges
Read more12 Nov 2021 07:58
LONDON MARKET PRE-OPEN: Astra revenue up; Wood reviews Consulting unit
LONDON MARKET PRE-OPEN: Astra revenue up; Wood reviews Consulting unit
Read more12 Nov 2021 07:32
UPDATE 4-AstraZeneca starts to make modest profit from COVID-19 vaccine
(Repeats to fix story link)* Vaccine adds one cent to Q3 EPS* Co expects profit from shot to offset antibody costs* Q3 sales jump 47%, but costs bite* 2021 sales outlook improved, profit maintained* Shares down 4.5%By Pushkala Aripaka and Ludwig Burg...
Read more12 Nov 2021 07:32
UPDATE 4-AstraZeneca starts to make modest profit from COVID-19 vaccine
* Vaccine adds one cent to Q3 EPS* Co expects profit from shot to offset antibody costs* Q3 sales jump 47%, but costs bite* 2021 sales outlook improved, profit maintained* Shares down 4.5% (Releads, adds CEO comment)By Pushkala Aripaka and Ludwig Bu...
Read more12 Nov 2021 07:13
AstraZeneca makes over $1 bln in Q3 vaccine sales, small profit
Nov 12 (Reuters) - AstraZeneca on Friday posted $1.05 billion in COVID-19 vaccine sales for the third quarter and the not-for-profit vaccine added one cent to profit in the period, while the company reiterated its forecasts for 2021.(Reporting by ...
Read more12 Nov 2021 07:03
AstraZeneca holds guidance as Covid vaccine turns profitable
(Sharecast News) - AstraZeneca on Friday reported $1.05bn in third-quarter Covid vaccine sales as the not-for-profit drug added 1% to earnings in the period, while the company reiterated annual forecasts for 2021.
Read more11 Nov 2021 14:15
Friday preview: US consumer confidence, AstraZeneca in focus
(Sharecast News) - Financial markets' focus at the end of the week will shift back towards the US.
Read more